疫苗前沿 | Moderna：第三针疫苗提升Delta变种中和能力42倍，15个项目进入临床开发

 

 

参考资料：

[1] KRAS vaccine (mRNA-5671). Retrieved August 5, 2021, from https://investors.modernatx.com/static-files/12f15d58-0a61-4ca4-a3e1-61d06ab28e0c

[2] Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates. Retrieved August 5, 2021, from https://investors.modernatx.com/news-releases/news-release-details/moderna-reports-second-quarter-fiscal-year-2021-financial

[3] Business Updates Second Quarter 2021 Financial Results. Retrieved August 5, 2021, from https://investors.modernatx.com/static-files/c43de312-8273-4394-9a58-a7fc7d5ed098